Surgery Websites
Kratz Lab »  Research »  Drug Development

Identifying Genetic and Immunological Targets for Novel Interventions in High Risk Early Stage Lung Cancer

Shu Liu Phd And Computational ChemistryThe lab will leverage new new research discoveries to identify potential genetic and immunological targets of novel interventions such as biomarker-directed therapies, novel drugs and new immune-based therapies. Identification of these biomarkers and targets will allow the delivery of post-surgical interventions that patients with high-risk early-stage thoracic malignancies urgently need.